Want access to multiple medication options: If you and your clinician want the flexibility to choose from branded GLP-1 injectables, oral options, non-GLP-1 medications, and compounded alternatives under one clinical umbrella, Found Health describes a wide range of medication options within its program
For instance, a large network meta-analysis showed that SGLT-2 inhibitors reduced hospitalization for HF and renal composite outcome more than GLP-1RA [15], and that in patients with cardiovascular disease, SGLT-2 inhibitors show significant reduction in both heart failure (HF) hospitalizations and mortality for patients with HF and reduced ejection fraction [16]
Losing weight quickly can reduce bone density and raise the risk of osteoporosis and fractures over time
Here is the honest version
However, not all tested GLP-1RAs have consistently demonstrated reductions in cardiovascular events, and the impact on specific cardiovascular outcomes varied among the effective drugs
severe rash or hives